Biomatics Capital

About The Fund

Biomatics Capital is a venture capital firm based in Seattle, Washington, founded in 2016 with a focus on revolutionizing the healthcare industry through strategic investments. The firm targets the healthcare, technology, and life science sectors, with an emphasis on companies operating in the BioTech, Medical Devices (& Hospital Services), and Life Science verticals. Biomatics Capital aims to transform health care and medicine by leveraging the intersection of genomics and digital data, fostering the development of superior therapeutics, diagnostics, and delivery models. Their investment thesis is based on the conviction that breakthrough science can radically change medicine into a value-based healthcare system, which can lead to reduced healthcare costs and improved patient outcomes. Operating with a hands-on approach, Biomatics Capital provides invaluable counsel, becoming a strategic partner that offers both scientific and business insights, ensuring companies have the greatest chance for success. They engage deeply with portfolio companies, advising on business model refinement, research & development planning, and fundraising strategies, offering a network of experts to scale companies efficiently and effectively. The fund has stated minimum and maximum investment limits of $30 million, suggesting they are focused on allocations that can significantly impact a company's trajectory and commit to meaningful partnerships. Their testimonials reflect a firm that is highly committed and collaboratively engaged with the entrepreneurs they invest in, with a reputation for providing substantial value beyond capital allocation.